Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON
  1. Accueil Zonebourse
  2. Actions
  3. France
  4. Euronext Paris
  5. VALBIOTIS
  6. Actualités
  7. Autres langues
    ALVAL   FR0013254851

VALBIOTIS

(ALVAL)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur VALBIOTIS
01/12GLOBAL MARKETS LIVE : Merck, Volkswagen, Salesforce, Roche, Mondelez...
01/12Valbiotis Submits to the Competent Authorities the Three Clinical Protocols for TOTUM?8..
15/11Valbiotis Announces Positive Preclinical Results for TOTUM?070 in Hypercholesterolemia,..
30/09VALBIOTIS : Rapport financier semestriel 2021
30/09VALBIOTIS : Publication of 2021 half-year results
30/09Valbiotis Reports Earnings Results for the First Half 2021
24/09VALBIOTIS : Enters Joint Research Project on Natural Health
24/09MICROALGAE : exclusive agreement with IFREMER and ADECAL Technopole
24/09Valbiotis Consolidates Its Development of Innovative Natural Health Solutions by Integr..
09/09VALBIOTIS : Release of Letter to Shareholders for 2021
06/09VALBIOTIS : Completion of recruitment for the Phase II HEART clinical study conducted with..
06/09Valbiotis Announces the Completion of Recruitment for the Phase II HEART Clinical Study..
27/07VALBIOTIS : Release of the Universal Registration Document (R.21-039)
29/06EN DIRECTO DESDE LOS MERCADOS : Airbus, Alcon, FactSet, Wells Fargo, Ford, UBS, Zalando...
28/06VALBIOTIS : Implementation of the TOTUM•63 mode of action clinical study by INAF at L..
28/06Valbiotis Announces the Implementation of the Totum•63 Mode of Action Clinical Study by..
07/06VALBIOTIS : Appointment of Sébastien BESSY as Chief Operating Marketing and Business Offic..
07/06Valbiotis Appoints Sébastien Bessy as Chief Operating Marketing and Business Officer
03/06VALBIOTIS : Publication of the first scientific papers on TOTUM•63 in three internati..
03/06Valbiotis Announces the Publication of the First Scientific Papers on TOTUM•63 in Three..
26/05VALBIOTIS : granted a € 1.25 million innovation support loan by Bpifrance
20/05GLOBAL MARKETS LIVE : Ford, Intel, Cisco, EasyJet, Oatly...
12/05VALBIOTIS : rsquo; Combined General Meeting on May 27, 2021 will exceptionally be held beh..
12/05VALBIOTIS : AGM 2021 – Special Auditors' report – Res. 15 (in French)
16/04VALBIOTIS : Investors presentation – April 2021
15/04Empresas con mucha energía
15/04EN DIRECTO DESDE LOS MERCADOS : Dell, Thermo Fisher, ABB, TSMC, Deliveroo, McPhy, Publicis..
15/04OPINIONES DE LOS ANALISTAS DEL DÍA : LVMH, Eurofins, Virbac, Shop Apotheke, Jet2, Orsted, ..
12/04VALBIOTIS : Reportd Positive Preclinical Results Of Hypertension Drug
12/04Renacimiento inglés y pausa en los índices
12/04EN DIRECTO DESDE LOS MERCADOS : Airbus, Sanofi, Stellantis, Total, Valneva, Solutions 30, ..
12/04Valbiotis Reveals Positive Totum•854 Preclinical Results in the Prevention of Hypertens..
23/03¿Necesita un respiro?
23/03VALBIOTIS : erhält die ISO 9001-Zertifizierung für seine Aktivitäten im Bereich „Des..
22/03VALBIOTIS : obtains ISO 9001 certification for its activities in “Design, developmen..
22/03VALBIOTIS : Obtains ISO 9001 Certification for Its Activities in "Design, Development and ..
22/03VALBIOTIS Obtains ISO 9001 Certification for Its Activities in "Design, Development and..
19/03VALBIOTIS : veröffentlicht seine Jahresbilanz 2020
17/03VALBIOTIS : Releases Its 2020 Annual Results
17/03Valbiotis SA Reports Earnings Results for the Year Ended December 31, 2020
17/03VALBIOTIS : Investors presentation – March 2021
12/03VALBIOTIS : Kalender der Finanzkommunikation für 2021
11/03VALBIOTIS : 2021 Financial Communication Calendar
09/03VALBIOTIS : wird Ergebnisse zu TOTUM-854 bei arterieller Hypertonie auf der Jahrestagung d..
09/03Si tienes tecnología, has fallado en tu vida.
08/03VALBIOTIS : Selected to Present TOTUM-854's Results on Arterial Hypertension at the Annual..
08/03Valbiotis Selected to Present TOTUM-854 Results on Arterial Hypertension
23/02VALBIOTIS : meldet erste Visite des ersten Patienten im Rahmen der klinischen Phase-II-Stu..
22/02VALBIOTIS : Announces the First Patient's First Visit in the Phase II HEART Clinical Study..
22/02Valbiotis SA Announces the First Patient’s First Visit in the Phase II HEART Clinical S..
16/02VALBIOTIS : Investor presentation – February 2021
16/02VALBIOTIS : autorisiert den Start von HEART, der multizentrischen klinischen Phase-II-Stud..
15/02VALBIOTIS : Authorized to Launch HEART, the Phase II Multi-center Clinical Study With TOTU..
15/02Valbiotis Authorizes to Launch Heart, the Phase II Multi-Center Clinical Study with TOT..
02/02VALBIOTIS : Investor presentation – February 2021
26/01VALBIOTIS : Investor presentation – January 2021
11/01VALBIOTIS : kündigt Teilnahme an der 39. jährlichen J.P. Morgan Healthcare Conference und ..
11/01VALBIOTIS : Investor presentation – January 2021
11/01VALBIOTIS : Announces Its Participation in the 39th J.P. Morgan Healthcare Annual Conferen..
2020VALBIOTIS : präsentiert erste Marktdaten zur unbehandelten LDL-Hypercholesterinämie für TO..
2020VALBIOTIS : presents the first market data on untreated LDL-hypercholesterolemia for TOTUM..
2020VALBIOTIS : Investors presentation – November 2020
2020VALBIOTIS : Presents the First Market Data on Untreated LDL-hypercholesterolemia For TOTUM..
2020VALBIOTIS Presents the First Market Data on Untreated LDL-hypercholesterolemia For TOTU..
2020VALBIOTIS : in den EnterNext© PEA-PME 150 Index der Euronext Paris aufgenommen
2020VALBIOTIS : Integrates The EnterNext© PEA-PME 150 Index From Euronext Paris
2020VALBIOTIS : veröffentlicht Halbjahresergebnisse für 2020 und gibt einen aktuellen Überblic..
2020VALBIOTIS : Investors presentation – October 2020
2020VALBIOTIS : publishes its 2020 half-year results and provides an update on its global stra..
2020VALBIOTIS : Publishes Its 2020 Half-Year Results and Provides an Update on Its Global Stra..
2020Valbiotis Sa Reports Earnings Results for the Half Year Ended June 30, 2020
2020VALBIOTIS : wurde von der European Association for the Study of Diabetes (EASD) zur Vorste..
2020VALBIOTIS : Investors presentation – September 2020
2020VALBIOTIS : Investors presentation – July 2020
2020VALBIOTIS : selected to present 3 studies on TOTUM-63 by the European Association for the ..
1  2  3Suiv.